About the Company - Biocon Ltd
Biocon Ltd. is a Public Limited Listed company incorporated on 29/11/1978 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24234KA1978PLC003417 and registration number is 003417. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1738.20 Cr. and Equity Capital is Rs. 600.30 Cr. for the Year ended 31/03/2022.
Management |
---|
Name | Position Held |
---|
Ms. Kiran Mazumdar Shaw | Executive Chairperson |
Mr. Siddharth Mittal | Managing Director & CEO |
Prof. Ravi Rasendra Mazumdar | Non Exe.Non Ind.Director |
Mr. Eric Vivek Mazumdar | Non Exe.Non Ind.Director |
Mr. Meleveetil Damodaran | Lead Independent Director |
Dr. Vijay Kumar Kuchroo | Independent Director |
Mr. Bobby Kanubhai Parikh | Independent Director |
Mr. Peter John Bains | Independent Director |
Mr. Naina Lal Kidwai | Independent Director |
Biocon Ltd. Share Price Update |
---|
Share Price | Value |
---|
Today | ₹233.15 |
Previous Day | ₹235.20 |
Basic Stock Data of Biocon Ltd
Market Cap | 28,310 Cr. |
---|
Current Price | 236 |
---|
High / Low | 287/192 |
---|
Stock P/E | 35.2 |
---|
Book Value | 158 |
---|
Dividend Yield | 0.64 % |
---|
ROCE | 5.92 % |
---|
ROE | 4.78 % |
---|
Face Value | 5.00 |
---|
Biocon Ltd Quarterly Results
Month | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|
Sales | 1,750 | 1,857 | 1,842 | 1,761 | 1,840 | 2,174 | 2,409 | 2,140 | 2,320 | 2,941 | 3,774 | 3,423 | 3,462 |
Expenses | 1,363 | 1,459 | 1,476 | 1,427 | 1,445 | 1,733 | 1,870 | 1,783 | 1,877 | 2,352 | 2,817 | 2,741 | 2,745 |
Operating Profit | 386 | 399 | 366 | 333 | 395 | 441 | 539 | 356 | 442 | 589 | 957 | 681 | 717 |
OPM % | 22% | 21% | 20% | 19% | 21% | 20% | 22% | 17% | 19% | 20% | 25% | 20% | 21% |
Other Income | 16 | 28 | 218 | 47 | 35 | 48 | 26 | 78 | 48 | -193 | 152 | 94 | 134 |
Interest | 6 | 5 | 34 | 20 | 22 | 15 | 10 | 20 | 30 | 120 | 249 | 233 | 248 |
Depreciation | 178 | 186 | 184 | 195 | 202 | 206 | 212 | 218 | 231 | 301 | 364 | 358 | 389 |
Profit before tax | 218 | 236 | 366 | 166 | 206 | 269 | 342 | 197 | 229 | -26 | 497 | 184 | 214 |
Tax % | 10% | 21% | 19% | 35% | 22% | 18% | 17% | 15% | 64% | 19% | 17% | 19% | 19% |
Net Profit | 195 | 187 | 296 | 108 | 160 | 220 | 284 | 167 | 82 | -21 | 414 | 149 | 173 |
EPS in Rs | 1.41 | 1.40 | 2.11 | 0.70 | 1.15 | 1.56 | 1.99 | 1.20 | 0.39 | -0.35 | 2.61 | 0.84 | 1.05 |
Biocon Ltd Quarterly Chart
Biocon Ltd Profit & Loss
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|
Sales | 2,086 | 2,485 | 2,877 | 3,090 | 3,347 | 3,891 | 4,123 | 5,514 | 6,300 | 7,143 | 8,184 | 11,174 | 12,457 |
Expenses | 1,569 | 1,942 | 2,190 | 2,394 | 2,957 | 2,912 | 3,294 | 4,121 | 4,725 | 5,562 | 6,391 | 8,762 | 9,788 |
Operating Profit | 517 | 543 | 687 | 696 | 390 | 980 | 829 | 1,394 | 1,575 | 1,581 | 1,793 | 2,412 | 2,670 |
OPM % | 25% | 22% | 24% | 23% | 12% | 25% | 20% | 25% | 25% | 22% | 22% | 22% | 21% |
Other Income | 62 | 255 | 56 | 158 | 639 | 173 | 228 | 340 | 228 | 260 | 72 | 18 | 100 |
Interest | 12 | 8 | 2 | 9 | 29 | 26 | 62 | 71 | 65 | 58 | 68 | 419 | 632 |
Depreciation | 174 | 179 | 204 | 221 | 249 | 277 | 385 | 448 | 552 | 715 | 814 | 1,113 | 1,254 |
Profit before tax | 392 | 610 | 538 | 624 | 751 | 850 | 610 | 1,215 | 1,186 | 1,068 | 983 | 897 | 884 |
Tax % | 14% | 16% | 20% | 15% | 19% | 19% | 26% | 17% | 27% | 21% | 22% | 28% | |
Net Profit | 338 | 513 | 431 | 528 | 609 | 688 | 453 | 1,003 | 871 | 846 | 772 | 643 | 624 |
EPS in Rs | 2.82 | 4.24 | 3.45 | 4.14 | 4.59 | 5.10 | 3.10 | 7.54 | 6.24 | 6.17 | 5.40 | 3.85 | 3.49 |
Dividend Payout % | 30% | 29% | 24% | 20% | 18% | 10% | 16% | 7% | 0% | 0% | 9% | 39% | |
Biocon Ltd Profit & Loss Yearly Chart
Biocon Ltd Growth
|
Compounded Sales Growth |
---|
10 Years:: | 16% |
5 Years:: | 22% |
3 Years:: | 21% |
TTM:: | 50% |
Biocon Ltd Growth
|
Compounded Profit Growth |
---|
10 Years:: | 6% |
5 Years:: | 13% |
3 Years:: | -3% |
TTM:: | 24% |
Biocon Ltd Growth
|
Stock Price CAGR |
---|
10 Years:: | 14% |
5 Years:: | -5% |
3 Years:: | -18% |
1 Year:: | -17% |
Biocon Ltd Growth
|
Return on Equity |
---|
10 Years:: | 10% |
5 Years:: | 9% |
3 Years:: | 7% |
Last Year:: | 5% |
No data available for the Balance Sheet data table.
Biocon Ltd Reserves and Borrowings Chart
Biocon Ltd Cash Flow
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|
Cash from Operating Activity | 594 | 471 | 561 | 211 | 371 | 640 | 662 | 1,155 | 1,283 | 1,160 | 1,177 | 1,852 |
Cash from Investing Activity | -398 | -358 | -904 | -491 | -1,138 | -510 | -684 | -703 | -1,505 | -3,651 | -1,662 | -14,260 |
Cash from Financing Activity | -186 | -9 | 426 | 186 | 1,068 | -178 | -240 | -242 | 388 | 2,564 | 242 | 13,049 |
Net Cash Flow | 10 | 105 | 83 | -94 | 300 | -47 | -261 | 210 | 165 | 72 | -243 | 641 |
|
Biocon Ltd Financial Efficiency Indicators Chart
No valid data available for the Shareholding
Biocon Ltd Shareholding Pattern Chart
No. of Biocon Ltd Shareholders
Biocon Ltd Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) |
---|
Mirae Asset Large Cap Fund | 12094696 | 0.92 | 329.22 |
SBI Contra Fund | 10592468 | 1.76 | 288.33 |
Mirae Asset Midcap Fund | 5101743 | 1.14 | 138.87 |
Aditya Birla Sun Life ELSS Tax Relief 96 | 5040563 | 0.97 | 137.2 |
SBI Balanced Advantage Fund | 5021205 | 0.55 | 136.68 |
ICICI Prudential India Opportunities Fund | 4617055 | 1.02 | 125.68 |
UTI Mid Cap Fund | 3421047 | 1.04 | 93.12 |
Sundaram Mid Cap Fund | 3000000 | 0.93 | 81.66 |
Sundaram Mid Cap Fund - Institutional Plan | 3000000 | 0.93 | 81.66 |
Kotak Equity Arbitrage Fund - Regular Plan | 2985000 | 0.3 | 81.25 |
Biocon Ltd Key Financial Ratios
Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
---|
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Basic EPS (Rs.) | 3.88 | 5.44 | 6.24 | 6.32 | 7.65 |
Diluted EPS (Rs.) | 3.87 | 5.42 | 6.19 | 6.30 | 7.60 |
Cash EPS (Rs.) | 16.02 | 14.93 | 13.59 | 11.86 | 24.16 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 187.31 | 78.87 | 70.09 | 61.52 | 111.77 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 187.31 | 78.88 | 70.10 | 61.53 | 111.78 |
Revenue From Operations / Share (Rs.) | 93.07 | 68.17 | 59.22 | 52.50 | 91.91 |
PBDIT / Share (Rs.) | 24.05 | 18.18 | 15.89 | 14.70 | 25.64 |
PBIT / Share (Rs.) | 14.78 | 11.40 | 9.93 | 10.10 | 18.17 |
PBT / Share (Rs.) | 8.86 | 9.91 | 9.56 | 10.12 | 20.23 |
Net Profit / Share (Rs.) | 6.75 | 8.15 | 7.63 | 7.26 | 16.70 |
NP After MI And SOA / Share (Rs.) | 3.85 | 5.40 | 6.17 | 6.24 | 15.09 |
PBDIT Margin (%) | 25.84 | 26.67 | 26.83 | 28.00 | 27.89 |
PBIT Margin (%) | 15.88 | 16.72 | 16.77 | 19.24 | 19.77 |
PBT Margin (%) | 9.52 | 14.54 | 16.14 | 19.28 | 22.01 |
Net Profit Margin (%) | 7.24 | 11.95 | 12.88 | 13.82 | 18.16 |
NP After MI And SOA Margin (%) | 4.14 | 7.92 | 10.42 | 11.87 | 16.41 |
Return on Networth / Equity (%) | 2.58 | 7.69 | 9.83 | 11.15 | 14.84 |
Return on Capital Employeed (%) | 4.07 | 8.26 | 8.32 | 11.61 | 11.91 |
Return On Assets (%) | 0.88 | 3.17 | 3.99 | 5.18 | 7.42 |
Long Term Debt / Equity (X) | 0.85 | 0.47 | 0.39 | 0.18 | 0.25 |
Total Debt / Equity (X) | 0.99 | 0.58 | 0.47 | 0.28 | 0.29 |
Asset Turnover Ratio (%) | 0.11 | 0.12 | 0.17 | 0.19 | 0.31 |
Current Ratio (X) | 1.45 | 2.19 | 1.81 | 1.33 | 1.61 |
Quick Ratio (X) | 0.95 | 1.59 | 1.36 | 0.97 | 1.27 |
Inventory Turnover Ratio (X) | 0.68 | 0.75 | 0.81 | 1.10 | 1.68 |
Dividend Payout Ratio (NP) (%) | 12.96 | 0.00 | 0.00 | 8.42 | 7.97 |
Dividend Payout Ratio (CP) (%) | 3.80 | 0.00 | 0.00 | 4.84 | 5.33 |
Earning Retention Ratio (%) | 87.04 | 0.00 | 0.00 | 91.58 | 92.03 |
Cash Earning Retention Ratio (%) | 96.20 | 0.00 | 0.00 | 95.16 | 94.67 |
Interest Coverage Ratio (%) | 6.89 | 32.29 | 33.05 | 27.19 | 21.69 |
Interest Coverage Ratio (Post Tax) (%) | 3.63 | 17.12 | 16.82 | 13.82 | 12.38 |
Enterprise Value (Cr.) | 44766.88 | 44360.07 | 51477.10 | 34040.50 | 37998.50 |
EV / Net Operating Revenue (X) | 4.01 | 5.42 | 7.24 | 5.40 | 6.89 |
EV / EBITDA (X) | 15.50 | 20.32 | 26.99 | 19.29 | 24.70 |
MarketCap / Net Operating Revenue (X) | 2.22 | 4.91 | 6.90 | 5.15 | 6.65 |
Retention Ratios (%) | 87.03 | 0.00 | 0.00 | 91.57 | 92.02 |
Price / BV (X) | 1.39 | 4.76 | 6.51 | 4.84 | 6.01 |
Price / Net Operating Revenue (X) | 2.22 | 4.91 | 6.90 | 5.15 | 6.65 |
EarningsYield | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
Biocon Ltd Profitability Ratios (%)
Biocon Ltd Liquidity Ratios
Biocon Ltd Liquidity Ratios (%)
Biocon Ltd Interest Coverage Ratios (%)
Biocon Ltd Valuation Ratios
Fair Value of Biocon Ltd Stock
Fair Value: ₹267.55
The stock is undervalued by 13.37% compared to the current price ₹236
*This is not Investment Advice
Strength and Weakness of Biocon Ltd Stock
Unable to fetch valid data for stock valuation.